JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration. NEXT EVENTS:
Thursday 2nd July 2020Assuring the quality of radio-labelled products from clinical trials to commercialisationVIRTUAL EVENT : 1pm-4:30pm (UK BST)
The use of radiolabelled materials in clinical trial, therapeutic and diagnostic applications presents many specialised challenges to assure their fitness for intended purpose. This symposium will examine the uses of radiolabelled materials, key regulatory requirements and best practices to assure their quality in clinical trials or commercialisation.
Low price £50
Dr Marie Croft - Pharmaron
Dr Philippe Dasse - Advanced Accelerator Applications
Dr Simona de Robertis - MHRA
Dr Neil Geach - Selcia
Victoria Gibson - Guys and St Thomas Hospital
Ian Harwood - MHRA
Justin Holland - Quotient Sciences
Jordi Vall-Llossera - Advanced Accelerator ApplicationsDETAILS AND REGISTRATION
Thursday 3rd December 2020Data integrity IIRoyal Society of Chemistry, London LAST EVENT:
Data integrity still continues to be a very hot topic for Industry and regulators alike. Data integrity still appears in the list of top five audit findings. This is a must attend meeting for anyone involved in addressing issues and challenges associated with data integrity.DETAILS AND REGISTRATION
Thursday 7th May 2020ICH Q3E (Extractables and Leachables): setting the sceneVIRTUAL EVENT : 1pm-4pm (UK BST)
ICH Q3E (Extractables and Leachables) has been adopted by the ICH governing body as ICH Q3E and will now progress through the various ICH stages that will culminate as an international harmonised guideline. This meeting will be an important event in understanding and trying to influence the outcome of the ICH Q3E proceedings.
Introductory Low Price: £25DETAILS
In line with the latest government advice on social distancing, JPAG has had to take a decision about its future programme of events. Therefore the symposia scheduled for May and July will not take place as conventional meetings.
JPAG has been working hard to offer these as on-line events, starting with the May and July programmes. Registrations for these events are proceeding so book now at the low introductory price and enjoy the new style of learning experience.
If any event is cancelled without the option of an alternative format and you have paid a registration fee then this will be refunded. Please note the Terms and Conditions (which are on the JPAG website) concerning travel expenses.
Thank you for your understanding at this difficult time.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical ReviewTESTIMONIALS:Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
JPAG members can receive a free hard copy subscription to EPRclick here
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
Covid-19 a wakeup call?
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Covid-19 a wake-up call" written by Dr Dave Elder, Past-Chairman of the JPAG Committee More...Monday 20th April 2020
The role of ELSIE in evolving current thinking on extractables and lea
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "The role of ELSIE in evolving current thinking on extractables and leachables" written by Dr Dave Elder, Past-Chairman of the JP...More...Wednesday 19th February 2020
ICH M9: biopharmaceutics classification system-based biowaivers
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "ICH Q12: "ICH M9: biopharmaceutics classification system-based biowaivers" written by Dr Dave Elder, Past-Chairman of the JPAG C...More...Monday 6th January 2020
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).